Article
What’s so controversial about microdosing?
The incredible mainstream press microdosing has received has managed to avoid many discussions.
Brett Greene is a founder, director, and Chief Strategy Officer of Adelia Therapeutics.
Article
The incredible mainstream press microdosing has received has managed to avoid many discussions.
Article
Icaros: A Vision opens Friday, May 19th 2017 at Metrograph in NYC, followed by a national rollout in several cities in the U.S. and overseas.
Article
What if honest drug education, harm reduction, long term integration, and acknowledging risks, took the place of propaganda?
Psymposia is a research and media 501(c)(3) nonprofit that offers critical perspectives on drugs, politics, and culture. We rely on audience support to keep our work independent and focused on the public interest. You can sustain Psymposia by becoming a member, which includes exclusive content and perks.